Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors


Approval of Zynrelef by Health Canada for the management of postoperative pain – Heron Therapeutics

Written by | 28 Jun 2022

Heron Therapeutics, Inc., announced that Health Canada has issued a Notice of Compliance (NOC) to commercialize Zynrelef (bupivacaine and meloxicam extended-release solution) for instillation into the surgical wound… read more.

Heron Therapeutics announces FDA approval of Zynrelef for the management of postoperative pain for up to 72 hours

Written by | 21 May 2021

Heron Therapeutics, Inc. announced that the FDA has approved Zynrelef (bupivacaine and meloxicam) extended-release solution for use in adults for soft tissue or periarticular instillation to produce postsurgical… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.


You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.